MENU
+Compare
ORGO
Stock ticker: NASDAQ
AS OF
Sep 26, 04:59 PM (EDT)
Price
$4.09
Change
-$0.59 (-12.61%)
Capitalization
593.69M

ORGO Organogenesis Holdings Forecast, Technical & Fundamental Analysis

Organogenesis Holdings Inc is a regenerative medicine company focused on the development, manufacture, and commercialization of product solutions for the advanced wound care, surgical, and sports medicine markets... Show more

ORGO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
a Summary for ORGO with price predictions
Sep 25, 2025

Aroon Indicator for ORGO shows an upward move is likely

ORGO's Aroon Indicator triggered a bullish signal on September 11, 2025. Tickeron's A.I.dvisor detected that the AroonUp green line is above 70 while the AroonDown red line is below 30. When the up indicator moves above 70 and the down indicator remains below 30, it is a sign that the stock could be setting up for a bullish move. Traders may want to buy the stock or look to buy calls options. A.I.dvisor looked at 172 similar instances where the Aroon Indicator showed a similar pattern. In of the 172 cases, the stock moved higher in the days that followed. This puts the odds of a move higher at .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. of 62 cases where ORGO's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where ORGO advanced for three days, in of 289 cases, the price rose further within the following month. The odds of a continued upward trend are .

ORGO may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on September 25, 2025. You may want to consider selling the stock, shorting the stock, or exploring put options on ORGO as a result. In of 86 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

The Moving Average Convergence Divergence Histogram (MACD) for ORGO turned negative on September 08, 2025. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 50 similar instances when the indicator turned negative. In of the 50 cases the stock turned lower in the days that followed. This puts the odds of success at .

ORGO moved below its 50-day moving average on September 25, 2025 date and that indicates a change from an upward trend to a downward trend.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where ORGO declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

Fundamental Analysis (Ratings)

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. ORGO’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (2.545) is normal, around the industry mean (16.880). P/E Ratio (63.750) is within average values for comparable stocks, (73.296). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (1.947). ORGO has a moderately low Dividend Yield (0.000) as compared to the industry average of (0.030). P/S Ratio (1.405) is also within normal values, averaging (45.617).

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. ORGO’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 91, placing this stock worse than average.

View a ticker or compare two or three
ORGO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published Earnings

ORGO is expected to report earnings to fall 162.90% to 6 cents per share on November 05

Organogenesis Holdings ORGO Stock Earnings Reports
Q3'25
Est.
$0.06
Q2'25
Missed
by $0.05
Q1'25
Missed
by $0.13
Q4'24
Beat
by $0.05
Q3'24
Beat
by $0.11
The last earnings report on August 07 showed earnings per share of -10 cents, missing the estimate of -5 cents. With 517.49K shares outstanding, the current market capitalization sits at 593.69M.
A.I. Advisor
published General Information

General Information

a financial conglomerate

Industry PharmaceuticalsGeneric

Profile
Fundamentals
Details
Industry
Financial Conglomerates
Address
85 Dan Road
Phone
+1 781 575-0775
Employees
862
Web
https://www.organogenesis.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
RYKCX85.91N/A
N/A
Rydex Banking C
RAGTX75.76N/A
N/A
Virtus Zevenbergen Technology A
ALCZX23.34N/A
N/A
Alger International Opportunities Z
GLVYX91.53N/A
N/A
Invesco Global Focus Y
LTFOX20.95N/A
N/A
Lord Abbett Affiliated F3

ORGO and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, ORGO has been loosely correlated with ANIP. These tickers have moved in lockstep 49% of the time. This A.I.-generated data suggests there is some statistical probability that if ORGO jumps, then ANIP could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ORGO
1D Price
Change %
ORGO100%
-4.49%
ANIP - ORGO
49%
Loosely correlated
-1.71%
PRGO - ORGO
46%
Loosely correlated
-2.95%
ANIK - ORGO
33%
Poorly correlated
-0.77%
GTBIF - ORGO
29%
Poorly correlated
-7.42%
AMRX - ORGO
29%
Poorly correlated
-1.13%
More

Groups containing ORGO

Correlation & Price change

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ORGO
1D Price
Change %
ORGO100%
-4.49%
Pharmaceuticals: Generic
industry (224 stocks)
31%
Poorly correlated
+0.11%